Literature DB >> 6249748

Antibody-mediated neutralization of virus is abrogated by mycoplasma.

C Dickson, J Elkington, A Hales, R Weiss.   

Abstract

The ability of a mouse mammary tumor cell line to abrogate antibody neutralization of vesicular stomatitis virus was shown to be due to the presence of mycoplasma. The mycoplasma was isolated from the cell line and typed as Mycoplasma orale. Colonies of this mycoplasma were used to deliberately infect cell cultures which then gained the capacity to reactivate antibody-neutralized virus. The extent of the reactivation depended on the source of neutralizing antiserum. Other species of mycoplasma were tested and were found to reactivate neutralized virus, indicating that this may be a general phenomenon of mycoplasma contamination.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6249748      PMCID： PMC550999          DOI： 10.1128/iai.28.3.649-653.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Plaque assay of avian sarcoma viruses using casein.

Authors:  P C Balduzzi; H Murphy
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

2.  Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus.

Authors:  R A Weiss; D Boettiger; H M Murphy
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

3.  Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus.

Authors:  J Závada; C Dickson; R Weiss
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

4.  VSV pseudotype particles with the coat of avian myeloblastosis virus.

Authors:  J Závada
Journal:  Nat New Biol       Date:  1972-11-22

5.  Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production.

Authors:  A R Goldberg
Journal:  Cell       Date:  1974-06       Impact factor: 41.582

6.  [Genetic study of vesicular stomatitis virus: classification of spontaneous thermosensitive mutants into complementation groups].

Authors:  A Flamand
Journal:  J Gen Virol       Date:  1970-09       Impact factor: 3.891

7.  Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: assay by molecular hybridization.

Authors:  G Ringold; E Y Lasfargues; J M Bishop; H E Varmus
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

8.  Detection of mycoplasma in cell cultures.

Authors:  W House; A Waddell
Journal:  J Pathol Bacteriol       Date:  1967-01

9.  [Analysis of a thermolabile mutant of vesicular stomatitis virus (VSV)].

Authors:  V Deutsch; A Berkaloff
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-07

10.  Nucleoside incorporation into strain L cells: inhibition by pleuropneumonia-like organisms.

Authors:  R M Nardone; J Todd; P Gonzalez; E V Gaffney
Journal:  Science       Date:  1965-09-03       Impact factor: 47.728
View more
  4 in total

1.  Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.

Authors:  M C Walker; J R Masters; C N Parris; P J Hepburn; P J English
Journal:  Urol Res       Date:  1986

2.  Localization of the receptor gene for type D simian retroviruses on human chromosome 19.

Authors:  M A Sommerfelt; B P Williams; A McKnight; P N Goodfellow; R A Weiss
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.

Authors:  P J Hepburn; R T Oliver; P A Riley; B T Hill; J R Masters
Journal:  Urol Res       Date:  1985

Review 4.  Beware of Mycoplasma Anti-immunoglobulin Strategies.

Authors:  Yonathan Arfi; Carole Lartigue; Pascal Sirand-Pugnet; Alain Blanchard
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.